These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 9857194)

  • 21. Avian erythroleukemia: a model for corepressor function in cancer.
    Rietveld LE; Caldenhoven E; Stunnenberg HG
    Oncogene; 2001 May; 20(24):3100-9. PubMed ID: 11420726
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The v-erbA oncogene (review).
    Thormeyer D; Baniahmad A
    Int J Mol Med; 1999 Oct; 4(4):351-8. PubMed ID: 10493974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The c-erbA alpha-encoded thyroid hormone receptor is phosphorylated in its amino terminal domain by casein kinase II.
    Glineur C; Bailly M; Ghysdael J
    Oncogene; 1989 Oct; 4(10):1247-54. PubMed ID: 2552374
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GATA-4 binds to an upstream element of the human alpha2(I) collagen gene (COL1A2) and inhibits transcription in fibroblasts.
    Wang L; Tanaka S; Ramirez F
    Matrix Biol; 2005 Aug; 24(5):333-40. PubMed ID: 15982862
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The nuclear oncogenes v-erbA and v-ets cooperate in the induction of avian erythroleukemia.
    Metz T; Graf T
    Oncogene; 1992 Mar; 7(3):597-605. PubMed ID: 1347919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. V-erbA and c-erbA proteins enhance transcriptional activation by c-jun.
    Sharif M; Privalsky ML
    Oncogene; 1992 May; 7(5):953-60. PubMed ID: 1349165
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Promoter specific sensitivity to inhibition of histone deacetylases: implications for hormonal gene control, cellular differentiation and cancer.
    Dressel U; Renkawitz R; Baniahmad A
    Anticancer Res; 2000; 20(2A):1017-22. PubMed ID: 10810390
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.
    Choi KC; Oh SY; Kang HB; Lee YH; Haam S; Kim HI; Kim K; Ahn YH; Kim KS; Yoon HG
    Biochem J; 2008 Apr; 411(1):19-26. PubMed ID: 18052923
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Requirements for repression of retinoid X receptor by the oncoprotein P75gag-v-erbA and the thyroid hormone receptors.
    Wahlström GM; Vennström B
    Mol Endocrinol; 1998 May; 12(5):645-53. PubMed ID: 9605927
    [TBL] [Abstract][Full Text] [Related]  

  • 30. v-erbA oncogene activation entails the loss of hormone-dependent regulator activity of c-erbA.
    Zenke M; Muñoz A; Sap J; Vennström B; Beug H
    Cell; 1990 Jun; 61(6):1035-49. PubMed ID: 1972036
    [TBL] [Abstract][Full Text] [Related]  

  • 31. c-erbA and v-erbA modulate growth and gene expression of a mouse glial precursor cell line.
    Iglesias T; Llanos S; López-Barahona M; Pérez-Aranda A; Rodríguez-Peña A; Bernal J; Höhne A; Seliger B; Muñoz A
    Cell Growth Differ; 1994 Jul; 5(7):697-704. PubMed ID: 7947384
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological effects of the v-erbA oncogene in transformation of avian erythroid cells.
    Vennström B; Beug R; Damm K; Engel D; Gehring U; Graf T; Muñoz A; Sap J; Zenke M
    Horm Metab Res Suppl; 1987; 17():14-9. PubMed ID: 2895057
    [No Abstract]   [Full Text] [Related]  

  • 33. Induction of differentiation of avian erythroblastosis virus-transformed erythroblasts by the protein kinase inhibitor H7: analysis of the transcription factor EF1.
    Nicolas RH; Partington G; Major GN; Smith B; Carne AF; Huskisson N; Goodwin G
    Cell Growth Differ; 1991 Mar; 2(3):129-35. PubMed ID: 1676294
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of a domain required for oncogenic activity and transcriptional suppression by v-erbA and thyroid-hormone receptor alpha.
    Damm K; Evans RM
    Proc Natl Acad Sci U S A; 1993 Nov; 90(22):10668-72. PubMed ID: 7902566
    [TBL] [Abstract][Full Text] [Related]  

  • 35. v-erbA stimulates quail myoblast differentiation in a T3 independent, cell-specific manner.
    Cassar-Malek I; Marchal S; Altabef M; Wrutniak C; Samarut J; Cabello G
    Oncogene; 1994 Aug; 9(8):2197-206. PubMed ID: 7913543
    [TBL] [Abstract][Full Text] [Related]  

  • 36. EGF promotes in vivo tumorigenic growth of primary chicken embryo fibroblasts expressing v-myc and enhances in vitro transformation by the v-erbA oncogene.
    Khazaie K; Panayotou G; Aguzzi A; Samarut J; Gazzolo L; Jurdic P
    Oncogene; 1991 Jan; 6(1):21-8. PubMed ID: 1671532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dimerization of v-erbA on inverted repeats.
    Zubkova I; Subauste JS
    Biochem Biophys Res Commun; 2002 May; 294(1):35-41. PubMed ID: 12054736
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Leukemic transformation of normal murine erythroid progenitors: v- and c-ErbB act through signaling pathways activated by the EpoR and c-Kit in stress erythropoiesis.
    von Lindern M; Deiner EM; Dolznig H; Parren-Van Amelsvoort M; Hayman MJ; Mullner EW; Beug H
    Oncogene; 2001 Jun; 20(28):3651-64. PubMed ID: 11439328
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Negative regulation of bcl-2 expression by p53 in hematopoietic cells.
    Wu Y; Mehew JW; Heckman CA; Arcinas M; Boxer LM
    Oncogene; 2001 Jan; 20(2):240-51. PubMed ID: 11313951
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Estrogen receptor regulation of carbonic anhydrase XII through a distal enhancer in breast cancer.
    Barnett DH; Sheng S; Charn TH; Waheed A; Sly WS; Lin CY; Liu ET; Katzenellenbogen BS
    Cancer Res; 2008 May; 68(9):3505-15. PubMed ID: 18451179
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.